TrialPath

Find a study

Browse recruiting studies near you — free to check, always your choice.

Match me to a study

80 studies

Recruiting now, in plain language. Every study is watched over by an independent ethics board.

  • Asthma

    📍 Research Site · Mobile, AL · +27 more US sites · Get directions →

    A study to evaluate the efficacy and safety of benralizumab administered subcutaneously in patients ≥ 6 to \< 18 years of age with severe eosinophilic asthma, including a well-documented history of asthma exacerbations and uncontrolled asthma receiving high-dose inhaled corticosteroid (ICS) plus at least one additional controller medication.

    ✓ Study care freePhase 3Ages 6–18Learn more →
  • Asthma

    A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma

    Testing whether tezepelumab works and is safe for children with severe asthma

    📍 Research Site · Montgomery, AL · +29 more US sites · Get directions →

    To assess the efficacy and safety of tezepelumab in pediatric participants with severe uncontrolled asthma on medium to high-dose inhaled corticosteroids (ICS) and at least one additional asthma controller medication with or without oral corticosteroids.

    ✓ Study care freePhase 3Ages 5–11Learn more →
  • Anxiety

    Study to Evaluate the Efficacy and Safety of VQW-765 for the On-Demand Treatment of Social Anxiety Disorder

    Testing a single oral dose medicine versus placebo for social anxiety in adults

    📍 Vanda Investigational Site · Phoenix, AZ · +30 more US sites · Get directions →

    This is a multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of a single oral dose of VQW-765 compared to placebo in adults with social anxiety disorder.

    ✓ Study care freePhase 3Ages 18–65Learn more →
  • Anxiety

    Self-Adjusted Nitrous Oxide: A Feasibility Study in the Setting of Vasectomy

    Testing whether self-controlled nitrous oxide during vasectomy lowers pain and anxiety

    📍 Beth Israel Deaconess Medical Center · Boston, MA · Get directions →

    This study is being done to see if nitrous oxide during vasectomy decreases pain and anxiety, and also assess whether patients have better satisfaction when they control their own level of nitrous oxide during the procedure. If we find that patients experience less pain or anxiety with nitrous oxide, it could be suggested that self-adjusted nitrous oxide (SANO) may be a useful tool for improving experience of care during vasectomy.

    ✓ Study care freePhase 4Ages 21–85MenLearn more →
  • Dementia / Alzheimer's

    Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzheimer's Disease Dementia

    Testing the safety and effects of two drugs for agitation in Alzheimer’s dementia

    📍 Esperanza Clinical · Murrieta, CA · +8 more US sites · Get directions →

    The goal of this clinical trial is to evaluate the safety and efficacy of EXV-802 and EXV-801 in treatment of agitation in participants with Alzheimer's Disease dementia.

    ✓ Study care freePhase 2Ages 55–90Learn more →
  • Dementia / Alzheimer'sParkinson's disease

    PET Imaging Evaluation of [11C]SY08

    Testing a PET scan tracer to detect alpha-synuclein protein clumps in dementia and Parkinson’s

    📍 MGH · Charlestown, MA · Get directions →

    The overall goal of the proposed research is to evaluate the use of \[11C\]SY08 as a PET radiotracer for aggregated alpha synuclein (αS) in individuals with Parkinson's disease (PD), Multiple system atrophy (MSA), Dementia with Lewy Bodies (DLB) and healthy controls. The purpose of this study is to evaluate the use of \[11C\]SY08 as a PET radiotracer for αS fibrils in individuals with PD, MSA, DLB and healthy controls.

    ✓ Study care freeEarly Phase 1Ages 50–80Learn more →
  • Asthma

    A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)

    Testing an add-on treatment given every 6 months for severe asthma not controlled by inhaled

    📍 Research Site 13 · Bakersfield, CA · +12 more US sites · Get directions →

    The objective of this study is to assess the potential for GB-0895 treatment to improve the health of adolescents and adults with severe asthma that is uncontrolled by inhaled corticosteroids (ICS) and conventional asthma controllers. The study details include: Study treatment: randomized to receive either GB-0895 or placebo administered every 6 months over 52 weeks.

    ✓ Study care freePhase 3Ages 12–80Learn more →
  • DepressionAnxiety

    Perinatal Depression & Anxiety (PDA) and Maternal Gut Microbiome

    Studying how gut bacteria in pregnant people relates to depression and anxiety

    📍 Sunnybrook Health Science Center · Toronto, Ontario · Get directions →

    Perinatal depression and anxiety (PDA) are the leading causes of maternal mortality in developed countries. Women with a history of depression have a 20 fold higher risk of PDA at subsequent pregnancies.

    ✓ Study care freePhase 2Ages 18–43WomenLearn more →
  • COPD (chronic lung disease)Asthma

    The Effects of Positive Airway Pressure on the Mucolytic Effects of NAC (TEAM)

    Testing whether positive airway pressure helps a lung medicine (NAC) reach mucus plugs in asthma or

    📍 UCSF Airway Clinical Research Center · San Francisco, CA · Get directions →

    The goal of this clinical trial is to determine if positive pressure during inspiration will improve penetration of aerosolized N-Acetylcysteine (NAC) into airway mucus plugs in the lungs of patients with asthma or Chronic Obstructive Pulmonary Disease (COPD). The main questions it aims to answer are: * Does delivery of aerosolized NAC with positive inspiratory pressure have a greater effect on mucus plug burden in the lungs than delivery of NAC without positive pressure.

    ✓ Study care freePhase 4Ages 18–85Learn more →
  • Asthma

    📍 Research Site · Chandler, AZ · +33 more US sites · Get directions →

    This study evaluates the efficacy and safety of benralizumab as an add-on therapy in uncontrolled eosinophilic asthma participants treated with medium-dose ICS-LABA compared to the conventional treatment step of escalation of inhaled therapy to high-dose ICS-LABA.

    ✓ Study care freePhase 3Ages 12–75Learn more →
  • DepressionAnxiety

    Nebulized Ketamine for the Treatment of Major Depressive Disorder

    Testing a breathing mist of ketamine to reduce symptoms of major depression

    📍 Maimonides Medical Center · Brooklyn, NY · Get directions →

    This is a double-blind active placebo controlled clinical trial for individuals with moderate to severe depression. The purpose of this study is to assess if nebulized ketamine can reduce depressive symptoms.

    ✓ Study care freePhase 3Ages 18–88Learn more →
  • Asthma

    Depemokimab Asthma Imaging and Bronchoscopy Sub-Study

    Testing a medicine in people with asthma to study lung changes

    📍 GSK Investigational Site · Brooksville, FL · +8 more US sites · Get directions →

    Asthma is a chronic condition marked by narrowed and swollen airways due to inflammation leading to recurring symptoms that can vary and worsen unpredictably.\\xa0The purpose of this study is to assess how depemokimab, a monoclonal antibody, affects the structure and function of the lungs in asthmatic participants with type 2 inflammation, characterized by an eosinophilic phenotype.

    ✓ Study care freePhase 3Ages 18+Learn more →
  • DepressionAnxiety

    Integrating Inuit Knowledge Principles in Multi-Level Mental Health Clinical Trials

    Testing whether eating more country foods and cultural activities help Inuit adults with depression

    📍 Aqqiumavvik Society · Arviat, Nunavut · Get directions →

    This study is looking at how eating more country foods affects mental health among Inuit men and women in Arviat, NU. The goal is to evaluate if eating more of these foods helps people feel less depressed or anxious, and whether being part of food-gathering and cultural activities also makes a difference.

    ✓ Study care freeEarly Phase 1Ages 18–65Learn more →
  • Dementia / Alzheimer's

    A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease

    Testing whether KarXT plus KarX-EC is safe and works for memory problems in Alzheimer’s disease

    📍 Healthy Brain Clinic · Long Beach, CA · +27 more US sites · Get directions →

    The purpose of this study is to evaluate the efficacy and safety of KarXT + KarX-EC for cognitive impairment in Alzheimer's Disease

    ✓ Study care freePhase 3Ages 60–85Learn more →
  • Asthma

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

    Studying what causes breathing out to get harder during asthma flare-ups

    📍 Arthur F Gelb Medical Corporation · Lakewood, CA · Get directions →

    The purpose of this study is to evaluate the site and mechanisms responsible for expiratory airflow limitation in chronic, treated, non-smoking, stable asthmatics with moderate to severe persistent expiratory airflow obstruction. Treatment will include inhaled corticosteroids and long acting beta2agonists.

    ✓ Study care freePhase 4Ages 10–80Learn more →
  • Dementia / Alzheimer's

    A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)

    Testing long-term safety and effectiveness of two medicines for agitation in Alzheimer’s dementia

    📍 Local Institution - 2609 · Chandler, AZ · +39 more US sites · Get directions →

    The purpose of this study is to evaluate the long-term efficacy and safety of combined formulation of xanomeline tartrate/trospium chloride in an immediate release (IR) capsule (KarXT) and xanomeline enteric capsules (KarX-EC) in participants with agitation associated with Alzheimer's Disease who completed the parent studies CN012-0023 or CN012-0024.

    ✓ Study care freePhase 3Ages 55–90Learn more →
  • Asthma

    Timely Administration of IV Magnesium Sulfate in Patients With a Moderate Asthma Exacerbation

    Testing early IV magnesium sulfate for people with a moderate asthma flare

    📍 Oklahoma Children's Hospital · Oklahoma City, OK · Get directions →

    This study aims to identify whether early administration of magnesium sulfate in moderate asthma exacerbations can potentially avoid admission, decrease length of stay in the emergency department (ED), decrease length of stay (LOS) in the general hospital floor vs pediatric intensive care unit (PICU), and decrease the need for respiratory support.

    ✓ Study care freeEarly Phase 1Ages 5–17Learn more →
  • DepressionAnxiety

    Creatine for Depressed Male and Female Methamphetamine Users

    Testing whether creatine helps depression and anxiety in people who use meth

    📍 Montana State University College of Nursing (Missoula campus) · Missoula, MT · Get directions →

    * Assess the antidepressant/anxiolytic effect of creatine in male and female methamphetamine users * Assess creatine's effect on methamphetamine use * Assess the safety of creatine in male methamphetamine users with depression

    ✓ Study care freePhase 3Ages 18–59Learn more →
  • Dementia / Alzheimer's

    Sex-Specific Effects of Endocrine Disruption on Aging and Alzheimer's Disease

    Studying whether ovarian hormones are linked to aging and Alzheimer’s risk in women

    📍 Mayo Clinic · Jacksonville, FL · +1 more US site · Get directions →

    The researchers are trying to determine whether ovarian hormones are associated with aging processes and with the risk of developing Alzheimer's disease in women.

    ✓ Study care freePhase 4Ages 60+WomenLearn more →
  • Dementia / Alzheimer's

    A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).

    Testing whether yearly donanemab helps people with dementia after a prior study

    📍 Banner Alzheimer's Institute · Phoenix, AZ · +39 more US sites · Get directions →

    The main purpose of this study is to determine if participants who previously took donanemab get clinical benefit when they receive annual doses. For each participant, the study will last up to 2.5 years and will include 6 visits.

    ✓ Study care freePhase 3Ages 55+Learn more →
  • Asthma

    A Study of Efficacy and Safety of Depemokimab Compared With Placebo in Adults and Adolescents With at Risk Type 2 Asthma

    Testing a medicine added to usual care to prevent asthma flare-ups in teens and adults with type 2

    📍 GSK Investigational Site · Newport Beach, CA · +7 more US sites · Get directions →

    The aim of this study is to evaluate the efficacy of depemokimab administered as an adjunctive therapy, in participants with Type 2 asthma at risk of exacerbations compared to the guideline recommended standard of care (SoC).

    ✓ Study care freePhase 3Ages 12+Learn more →
  • Asthma

    45th Multicenter Airway Research Collaboration

    Testing an emergency department treatment to prevent asthma attacks from coming back

    📍 MetroHealth · Cleveland, OH · Get directions →

    The study is a randomized controlled trial on the effect of emergency department initiation of Airsupra on acute asthma "recurrence" at 3 months and other related outcomes (acute asthma relapse, asthma control).

    ✓ Study care freePhase 4Ages 18–54Learn more →
  • Asthma

    Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS)

    Testing a skin injection of dupilumab for asthma in children ages 2 to under 6

    📍 Phoenix Children's Hospital- Site Number : 8400001 · Phoenix, AZ · +13 more US sites · Get directions →

    This is a parallel, Phase 3, 2-arm study to evaluate the efficacy and long-term safety of dupilumab treatment in children 2 to \<6 years of age with uncontrolled asthma and/or recurrent severe asthmatic wheeze. The study will be conducted in 2 parts.

    ✓ Study care freePhase 3Ages 2–5Learn more →
  • Asthma

    Leveraging Pharmacogenomics in Asthma for Predication, Mechanism and Endotyping

    Testing a new way to match asthma patients to biologic treatments using genetic and lab measures

    📍 Mayo Clinic · Scottsdale, AZ · +2 more US sites · Get directions →

    In this study, a new method will be used to evaluate response to 2 approved biologic therapies, and assess how well each patient responds to each asthma treatment. This study will measure the response to these treatments using genomic and biologic measurements obtained from participants biosamples.

    ✓ Study care freePhase 4Ages 18–75Learn more →
  • Dementia / Alzheimer's

    A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease

    Testing a drug called trontinemab for early Alzheimer’s disease dementia

    📍 Banner Alzheimer?s Institute · Phoenix, AZ · +32 more US sites · Get directions →

    The purpose of this study is to assess the efficacy and safety of trontinemab in participants with early symptomatic Alzheimer's disease (AD) (mild cognitive impairment \[MCI\] to mild dementia due to AD).

    ✓ Study care freePhase 3Ages 50–90Learn more →
  • Anxiety

    Pharmacogenetically-guided Escitalopram Treatment for Pediatric Anxiety: Aiming to Improve Safety and Efficacy (PrEcISE)

    Testing whether genetic-guided dosing of a daily anxiety medicine helps kids

    📍 University of Cincinnati, Department of Psychiatry & Behavioral Neuroscience · Cincinnati, OH · Get directions →

    This double-blind, 12-week study will consist include132 anxious youth who are randomized (1:1) to standard or pharmacogenetically-guided escitalopram dosing. Block randomization (1:1) will be stratified by sex and metabolizer status.

    ✓ Study care freePhase 4Ages 12–17Learn more →
  • Anxiety

    Adjunctive Treatment With L-methylfolate for Treatment-Resistant Generalized Anxiety Disorder: a Pilot Study

    Testing whether adding L-methylfolate is safe and tolerated for hard-to-treat anxiety

    📍 Kingston Health Sciences Centre · Kingston, Ontario · Get directions →

    The goal of this feasibility study is to determine the tolerability and safety of add on treatment with L-methylfolate in patients with treatment-resistant generalized anxiety disorder (GAD). The primary objective is to monitor for side effects and other risks associated with the treatment.

    ✓ Study care freePhase 4Ages 18–65Learn more →
  • Dementia / Alzheimer's

    A Study to Evaluate Safety and Efficacy of KarXT + KarX-EC as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-5)

    Testing a treatment called KarXT plus KarX-EC for psychosis in people with Alzheimer's disease

    📍 Gilbert Neurology Partners/CCT Research · Gilbert, AZ · +5 more US sites · Get directions →

    The purpose of this study is to evaluate KarXT + KarX-EC as a treatment for psychosis associated with Alzheimer's disease.

    ✓ Study care freePhase 3Ages 55–90Learn more →
  • Anxiety

    📍 Servicios Especializados En Ensayos Clinicos, Seec, Sc · Mexico City, Mexico City · Get directions →

    To evaluate the superiority of cognitive behavioral therapy using the Aurora® digital medical device + conventional drug treatment, compared to conventional drug treatment alone, in reducing anxiety symptoms, as assessed by the change in the GAD-7 scale at 12 weeks of treatment, relative to baseline.

    ✓ Study care freePhase 3Ages 18–65Learn more →
  • Asthma

    Azithromycin for Critical Asthma - Pediatrics

    Testing azithromycin in children with severe asthma to change the immune response

    📍 Johns Hopkins All Children's Hospital · St. Petersburg, FL · Get directions →

    The CR-AZI Study will assess the immunomodulatory effects of Azithromycin for pediatric Critical Asthma.

    ✓ Study care freePhase 2Ages 3–17Learn more →
  • DepressionDementia / Alzheimer's

    Aβ Dynamics in LLMD

    Testing how treating depression may change brain markers linked to Alzheimer’s

    📍 NYU Langone Health · New York, NY · +1 more US site · Get directions →

    This study will examine the biological factors that may modulate the relationship between depression and the development of Alzheimer's disease (AD). Since the direction of causation between depression and the biological factors associated with AD is unknown, the only way to understand cause and associated risk is to treat the depressive symptoms and examine the effects on AD biomarkers.

    ✓ Study care freePhase 4Ages 60+Learn more →
  • Asthma

    CHEST: A Collaboration With Community HEalth Centers to Implement SmarT for Asthma

    Helping community health clinic clinicians prescribe recommended asthma care

    📍 Affinia healthcare, 2220 Lemp Ave · St Louis, MO · +6 more US sites · Get directions →

    Purpose: This study aims to improve asthma care by helping clinicians at community health centers prescribe a guideline-recommended treatment called SMART (Single Maintenance and Reliever Therapy). The investigators will provide training and resources to clinicians, give feedback on prescribing patterns, and offer educational tools for patients and providers.

    ✓ Study care freePhase 4Ages 12+Learn more →
  • Dementia / Alzheimer's

    Epidemiology and Biomarker Study in Alzheimer's Disease

    Studying how memory changes over time and blood test results in people with dementia

    📍 Care Access - Houston · Houston, TX · Get directions →

    Study AACU determines rates of cognitive worsening in participants within elevated and not elevated plasma P-tau217 cohorts. Participation in AACU will last approximately 7 years.

    ✓ Study care freePhase 3Ages 55–75Learn more →
  • Dementia / Alzheimer's

    📍 Endeavor Health Systems · Evanston, IL · Get directions →

    CMK-0301 is a multi-site, randomized clinical trial to evaluate the safety and efficacy of \[F-18\]Flornaptitril-PET (F-18 FNT-PET) for the prediction of clinical progression of Mild Cognitive Impairment (MCI) with either Suspected Chronic Traumatic Encephalopathy (CTE) or Alzheimer's Disease (AD). The primary objectives of the study are to: (1) To determine the accuracy of F-18 FNT-PET in prediction of clinical decline and (2) To assess the safety and tolerability of F-18 FNT.

    ✓ Study care freePhase 3Ages 45+Learn more →
  • Dementia / Alzheimer's

    A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)

    Testing a treatment (KarXT plus KarX-EC) for memory problems in Alzheimer’s dementia

    📍 Fullerton Neurology and Headache Center · Fullerton, CA · +29 more US sites · Get directions →

    The purpose of this study is to evaluate the efficacy and safety of KarXT + KarX-EC for cognitive impairment in Alzheimer's Disease

    ✓ Study care freePhase 3Ages 60–85Learn more →
  • DepressionAnxiety

    Enhancing Transdiagnostic Mechanisms of Cognitive Dyscontrol (R33)

    Testing a cognitive training program to see brain and thinking changes in people with depression or

    📍 UC San Diego · San Diego, CA · Get directions →

    The proposed project aims to test the cognitive and neural effects of a cognitive training in a sample of individuals seeking treatment for anxiety, depression, or traumatic stress symptoms. Participants will be randomly assigned to one of two groups.

    ✓ Study care freePhase 2Ages 21–55Learn more →
  • Asthma

    A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)

    Testing an added medicine given every 6 months for severe asthma not controlled

    📍 Research Site 23 · Northridge, CA · +33 more US sites · Get directions →

    The objective of this study is to assess the potential for GB-0895 treatment to improve the health of adolescents and adults with severe asthma that is uncontrolled by inhaled corticosteroids (ICS) and conventional asthma controllers. The study details include: Study treatment: randomized to receive either GB-0895 or placebo administered every 6 months over 52 weeks.

    ✓ Study care freePhase 3Ages 12–80Learn more →
  • Dementia / Alzheimer's

    PET Imaging Tau Accumulation in FTLD and Atypical Alzheimer's Using [18F]-PI-2620

    Comparing tau brain scan images in different types of dementia

    📍 Perelman Center for Advance Medicine · Philadelphia, PA · Get directions →

    The investigators will compare \[18F\]-PI-2620 tau PET scans from patients with frontotemporal lobar degeneration (FTLD), patients with non-amnestic presentations of Alzheimer's disease (naAD), and demographically matched cognitively normal subjects.

    ✓ Study care freePhase 3Ages 18+Learn more →
  • Dementia / Alzheimer's

    A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-2)

    Testing a drug combination to treat agitation in adults with Alzheimer’s

    📍 Chandler Clinical Trials, LLC · Chandler, AZ · +39 more US sites · Get directions →

    The purpose of this study is to evaluate the efficacy and safety of KarXT + KarX-EC in adult participants with agitation related to Alzheimer's Disease.

    ✓ Study care freePhase 3Ages 55–90Learn more →
  • Asthma

    Ventilation and Perfusion in Asthmatics

    Testing how inhaled asthma medicines change breathing and blood flow in adults

    📍 University of Miami - Converge Miami · Miami, FL · Get directions →

    Assess regional changes to perfusion and ventilation from inhaled corticosteroid (ICS) and Fast-acting beta-antagonist (FABA) among adult asthmatics using radiographically derived estimates of regional ventilation (V-distribution), ventilation defect percentage (VDP), and ventilation heterogeneity (VH).

    ✓ Study care freePhase 4Ages 18–75Learn more →
  • Asthma

    Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma

    Comparing two as-needed inhalers to prevent severe asthma flare-ups in teens

    📍 Research Site · Anchorage, AK · +39 more US sites · Get directions →

    The purpose of this study is to compare the effect of budesonide/albuterol metered-dose inhaler (BDA MDI) with albuterol sulfate metered-dose inhaler (AS MDI), both administered as needed, on the annualized rate of severe asthma exacerbations in adolescents with a documented clinical diagnosis of asthma and at least one severe exacerbation in the prior year.

    ✓ Study care freePhase 3Ages 12–17Learn more →
  • Dementia / Alzheimer's

    Educational Support Group Program for Bilingual and Spanish-speaking Carepartners and People With Progressive Aphasia

    Testing an education and support group for people with progressive aphasia and their caregivers

    📍 University of Texas at Austin · Austin, TX · Get directions →

    The current study aims to examine the benefits of an education/support group program for individuals with progressive aphasia (caused by various etiologies, diagnoses) and their carepartners. The current study utilizes pre-, post-treatment, and follow-up assessments to measure effects of a psychoeducational support group and an implementation/communication skills training phase on measures of psychosocial function, communicative effectiveness and speech/language function.

    ✓ Study care freeEarly Phase 1Ages 18+Learn more →
  • Anxiety

    Cannabidiol-Assisted Learning for Managing Generalized Anxiety Disorder

    Testing cannabidiol added to talk therapy for adults with generalized anxiety

    📍 Wayne State University School of Medicine, Tolan Park Medical Building · Detroit, MI · Get directions →

    This randomized, double-blind, placebo-controlled clinical trial investigates the use of Food and Drug Administration (FDA)-approved cannabidiol (EPIDIOLEX®) as an adjunct to cognitive behavioral therapy (CBT) in adults with generalized anxiety disorder (GAD). The study aims to evaluate whether cannabidiol-assisted CBT enhances emotion regulation via dorsomedial prefrontal cortex (dmPFC) activation and improves anxiety symptom outcomes compared to CBT with placebo.

    ✓ Study care freePhase 3Ages 18–45Learn more →
  • Dementia / Alzheimer's

    Transcranial Magnetic Stimulation Treatment for Alzheimer's Disease

    Testing whether rTMS affects memory and brain function in dementia

    📍 Massachusetts General Hospital · Boston, MA · Get directions →

    In this research study we want to learn more about the effects of non-invasive brain stimulation on memory and brain-network function in cognitively unimpaired older adults and in patients with amnestic mild cognitive impairment (aMCI). This study will use a form of non-invasive brain stimulation called repetitive Transcranial Magnetic Stimulation (rTMS).

    ✓ Study care freeEarly Phase 1Ages 40–99Learn more →
  • Dementia / Alzheimer's

    A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)

    Testing the safety and side effects of Zunveyl in people with mild to moderate Alzheimer’s

    📍 Tekton Research Saint Louis Psychiatry · St Louis, MO · Get directions →

    The primary purpose of this study is to evaluate the safety and tolerability of Zunveyl® over 12 weeks of routine clinical use in adults with mild to moderate Alzheimer's disease.

    ✓ Study care freePhase 4Ages 50+Learn more →
  • Dementia / Alzheimer's

    A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease

    Testing trontinemab for safety and effectiveness in early Alzheimer’s disease dementia

    📍 University of Alabama at Birmingham · Birmingham, AL · +34 more US sites · Get directions →

    The purpose of this study is to assess the efficacy and safety of trontinemab in participants with early symptomatic Alzheimer's disease (AD) (mild cognitive impairment \[MCI\] to mild dementia due to AD).

    ✓ Study care freePhase 3Ages 50–90Learn more →
  • Dementia / Alzheimer's

    Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

    Screening people who may be eligible for Alzheimer’s disease studies for dementia

    📍 University of Alabama at Birmingham · Birmingham, AL · +39 more US sites · Get directions →

    This study is a pre-screening process used to assess participants' potential eligibility for Roche interventional Alzheimer's disease studies.

    ✓ Study care freePhase 3Ages 50–90Learn more →
  • Dementia / Alzheimer's

    Lemborexant for Insomnia in a Patient With Dementia: An N-of-1 Trial

    Testing a sleep medicine for insomnia symptoms in a person with dementia

    📍 Nova Scotia Health · Halifax, Nova Scotia · Get directions →

    Insomnia is a highly common, chronic disorder that is distressful for the patient but also for caregivers and can give rise to a heavy burden on the healthcare team. Sleeping aids like benzodiazepines and other sedatives (e.g., zolpidem, zopiclone) have been widely used to help treat insomnia.

    ✓ Study care freePhase 4Learn more →
  • Dementia / Alzheimer's

    A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

    Testing a medicine for psychosis in adults with moderate to severe Alzheimer’s

    📍 Local Institution - 1227 · Chandler, AZ · +39 more US sites · Get directions →

    The purpose of this study is to evaluate the safety and efficacy of KarXT in adult participants with mild to severe Alzheimer's Disease (AD) with moderate to severe psychosis related to AD.

    ✓ Study care freePhase 3Ages 55–90Learn more →
  • Asthma

    Magnesium Trial in Acute Asthma in Emergency Department

    Testing intravenous magnesium for children with severe asthma after ER treatment

    📍 Alberta Children's Hospital · Calgary, Alberta · Get directions →

    Despite optimal initial emergency department (ED) therapy, 50% of children with severe acute asthma have ongoing moderate-severe respiratory distress. Guidelines recommend intravenous magnesium (IVMg) for them, yet evidence for IVMg efficacy is scant and disparate.

    ✓ Study care freePhase 3Ages 2–17Learn more →
  • Dementia / Alzheimer's

    Biomarker Exploration in Aging, Cognition and Neurodegeneration

    Testing how MRI, PET scans, and memory tests can detect early dementia

    📍 University of California, Irvine · Irvine, CA · Get directions →

    The purpose of this research study is to understand the factors that underlie changes in thinking and memory with increasing age. The investigators will test the usefulness of MRI, PET, and cognitive testing in detecting subtle changes in the brain that precede cognitive decline.

    ✓ Study care freePhase 3Ages 60+Learn more →
  • Dementia / Alzheimer's

    A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

    Testing a potential Alzheimer disease treatment in people with early AD genetic risk

    📍 University of Alabama in Birmingham · Birmingham, AL · +10 more US sites · Get directions →

    The purpose of this research study is to test the study drug, referred to as remternetug, to determine its effectiveness for the study treatment of asymptomatic (at risk) Alzheimer disease in individuals with AD-causing mutations. This study will also investigate the effects of remternetug on biomarkers (measures of the disease including brain scans, blood and spinal fluid tests), examine safety data to identify any potential benefits or risks, and examine how well participants can tolerate remternetug.

    ✓ Study care freePhase 2Ages 18+Learn more →
  • Asthma

    📍 Teva Investigational Site 12087 · Phoenix, AZ · +39 more US sites · Get directions →

    The primary objective of the trial is to evaluate the efficacy of fluticasone propionate/albuterol sulfate multidose dry powder inhaler with electronic module (Fp/ABS eMDPI). Secondary objectives are: * To evaluate the efficacy of Fp/ABS eMDPI administered four times daily * To evaluate the safety and tolerability of Fp/ABS eMDPI administered four times daily over four weeks * To investigate the pharmacokinetics of Fp/ABS eMDPI, ABS eMDPI and Fp eMDPI after administration of a single dose The planned study duration for each participant is approximately 10 weeks, excluding an optional prescreening visit.

    ✓ Study care freePhase 3Ages 12+Learn more →
  • Anxiety

    Feasibility Study of Oral Ketamine Versus Placebo for the Treatment of Anxiety in Patients With Pancreatic Cancer

    Testing whether taking a mouth medicine works for anxiety in pancreatic cancer

    📍 Cedars-Sinai Medical Center · Los Angeles, CA · Get directions →

    This is a prospective, single center, double blind, randomized, crossover feasibility study of oral ketamine versus placebo for the treatment of anxiety in patients with pancreatic cancer currently receiving or within 12 weeks of receiving cancer targeted therapy. The primary objective is to determine the feasibility of enrolling subjects and treatment adherence.

    ✓ Study care freeEarly Phase 1Ages 18+Learn more →
  • Dementia / Alzheimer's

    Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's Type

    Testing a medicine called masupirdine versus placebo for agitation in Alzheimer’s dementia

    📍 Advanced Research Center, Inc. · Anaheim, CA · +26 more US sites · Get directions →

    This study will be conducted to evaluate the efficacy, safety, tolerability, and pharmacokinetics of masupirdine compared to placebo for the treatment of agitation in participants with dementia of the Alzheimer's type.

    ✓ Study care freePhase 3Ages 50–90Learn more →
  • Dementia / Alzheimer'sParkinson's disease

    Elucidating the Role of Cholinergic Degeneration in Cognitive Fluctuations in Lewy Body Dementia

    Studying how nerve cell loss affects thinking ups and downs in Lewy body dementia

    📍 Virginia Commonwealth University · Richmond, VA · Get directions →

    The proposed study aims to address the critical gaps in understanding the mechanisms of CF (Cognitive Fluctuations) by leveraging recently emerged molecular biomarkers, advanced neuroimaging techniques to assess measures of cholinergic degeneration, and synchronous EEG and assessments of attention. One of the overarching innovations of study is combining all of these assessments into one integrated research plan

    ✓ Study care freePhase 4Ages 50–89Learn more →
  • Asthma

    A Study Assessing the Effect of Dupilumab on Inducing Clinical Remission in Asthma

    Testing whether an asthma medicine can help people achieve full asthma control

    💵 May compensate

    📍 Sir Charles Gairdner Hospital · Nedlands, Western Australia · Get directions →

    This study tests whether an asthma medication called dupilumab can help people achieve complete asthma control (called "remission") when given earlier in their disease, before asthma becomes severe. Currently, most people with asthma only receive advanced treatments like biologics after their condition has worsened significantly and caused lung damage.

    ✓ Study care freePhase 3Ages 18–79Learn more →
  • Anxiety

    Sleep, Dreaming, and Virtual Reality for Mental Health

    Testing virtual reality and sleep or dreaming practices for anxiety

    📍 Northwestern University · Evanston, IL · +1 more US site · Get directions →

    People spend approximately one-third of their lives asleep, yet sleep is often underused as an opportunity to support psychological well-being. Contemplative traditions, including Tibetan Dream Yoga, have developed practices that use waking imagination and lucid dreaming to explore perception, awareness, and habitual patterns of thinking.

    ✓ Study care freeEarly Phase 1Ages 18+Learn more →
  • DepressionAnxiety

    Processes and Circuitry Underlying Threat Sensitivity as a Treatment Target for Co-morbid Anxiety and Depression

    Studying brain circuits for threat sensitivity in people with anxiety and depression

    📍 Laureate Institute for Brain Research · Tulsa, OK · Get directions →

    This mechanistic study uses an anti anxiety drug and brain imaging to study the threat processing system and associated brain circuits in people with depression, anxiety disorders and comorbid depression and anxiety disorders. In a double blind, placebo controlled crossover design, up to 65 individuals will be recruited who will have a diagnosis of major depressive disorder (MDD) and at least one anxiety disorder (AD) (AD-MDD group), up to 65 participants will have a diagnosis of MDD and no diagnosis of an AD and up to 65 participants will have no diagnosis of MDD and a diagnosis of at least one AD will be enrolled to participate in an two session study to obtain 150 completers (50 per group).

    ✓ Study care freePhase 4Ages 18–65Learn more →
  • Dementia / Alzheimer's

    Nighttime Agitation and Restless Legs Syndrome in People With Alzheimer's Disease

    Studying nighttime agitation and restless legs in people with Alzheimer’s

    📍 The University of Texas at Austin · Austin, TX · Get directions →

    Nighttime agitation in persons with Alzheimer's disease causes patient suffering, distresses caregivers, and often results in prescriptions for harmful antipsychotics. Effective treatments are lacking because of limited knowledge of the etiology of nighttime agitation.

    ✓ Study care freePhase 4Ages 55+Learn more →
  • Showing the first 60 of 80. Add filters or a location to narrow down.